Effects on Sperms’ Quality of Selegiline in Aged Rats
Huba Kalász1, *, Julianna Thuróczy2, Gellért Karvaly3, Lajos Balogh4, István Gyertyán1, Edit Tóth-Molnár5, Ernest Adeghate6, Kornélia Tekes7
Identifiers and Pagination:Year: 2017
First Page: 138
Last Page: 145
Publisher ID: TOMCJ-11-138
Article History:Received Date: 14/08/2017
Revision Received Date: 2/11/2017
Acceptance Date: 13/11/2017
Electronic publication date: 30/11/2017
Collection year: 2017
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4. 0 International Public License (CC-BY 4. 0), a copy of which is available at: https://creativecommons. org/licenses/by/4. 0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Selegiline is used to treat Parkinsonian patients. Other indications of its use have recently been discovered.
Scouting special and beneficial side effects of selegiline treatment.
Two-year old male Wistar rats were daily treated with 0.25 mg/kg of selegiline s.c. (subcutaneous injection). The rats were sacrificed following a four-weeks’ treatment.
Mass of testes, number of sperms, progressive motility of sperms, and their viability definitely increased.
Selegiline can successfully be used to stop/counterbalance certain symptoms of aging.